Josef Brüggen

Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl

Ellen Weisberg, Paul W. Manley, Werner Breitenstein et al. · Cancer Cell · 2005 · 1.5K citations · Full text

Pharmacy, Medicinal Chemistry, Molecular Biology +6

Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis

Karel Odink, Nico Cerletti, Josef Brüggen et al. · Nature · 1987 · 699 citations

Life Sciences, Cell Biology, Immunology +16

New Anilinophthalazines as Potent and Orally Well Absorbed Inhibitors of the VEGF Receptor Tyrosine Kinases Useful as Antagonists of Tumor-Driven Angiogenesis

Guido Bold, Karl‐Heinz Altmann, J Frei et al. · Journal of Medicinal Chemistry · 2000 · 213 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

Phenotypic dynamics of tumor progression in human malignant melanoma

Eva‐Bettina Bröcker, Ludwig Suter, Josef Brüggen et al. · International Journal of Cancer · 1985 · 169 citations

Medicine, Oncology, Pathology +17

Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl

Ellen Weisberg, Paul W. Manley, Werner Breitenstein et al. · Cancer Cell · 2005 · 105 citations · Full text

Pharmacy, Medicinal Chemistry, Molecular Biology +6